Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases

被引：0
|
作者：
Kawazoe, Mai [1 ]
Nishio, Junko [1 ,2 ]
Hirose, Wataru [3 ]
Furukawa, Karin [1 ]
Nanki, Toshihiro [1 ]
机构：
[1] Toho Univ, Sch Med, Dept Internal Med, Div Rheumatol, 6-11-1 Omori Nishi, Ota Ku, Tokyo 1438541, Japan
[2] Toho Univ, Sch Med, Dept Immunopathol & Immunoregulat, Tokyo, Japan
[3] Hirose Clin Rheumatol, Saitama, Japan
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2023年 / 115卷
关键词：
VACCINATION; AUTOIMMUNE;
D O I：
10.1016/j.ejim.2023.06.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：137 / 139
页数：3
相关论文
共 50 条
  • [41] Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
    Schulze-Koops, Hendrik
    Specker, Christof
    Skapenko, Alla
    RMD OPEN, 2021, 7 (01):
  • [42] Considerations on SARS-CoV-2 vaccines in patients with autoimmune blistering diseases
    Emanuele Cozzani
    Giulia Gasparini
    Laura Sticchi
    Roberto Russo
    Giancarlo Icardi
    Aurora Parodi
    European Journal of Dermatology, 2021, 31 : 415 - 417
  • [43] Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
    Regas, Valeria Herrera-Lasso
    Culla, Maria Teresa Dordal
    Bellfill, Ramon Lleonart
    MEDICINA CLINICA, 2020, 155 (10): : 448 - 453
  • [44] Adverse reactions of drugs specifically used for treatment of SARS-CoV-2 infection
    Tang, Mi
    Cai, Jianghui
    Tan, Jie
    MEDICINA CLINICA, 2021, 156 (11): : 576 - 576
  • [45] Antimalarial Drugs at the Intersection of SARS-CoV-2 and Rheumatic Diseases: What Are the Potential Opportunities?
    Abisheva, Saule
    Rutskaya-Moroshan, Kristina
    Nuranova, Gulnaz
    Batyrkhan, Tansholpan
    Abisheva, Anilim
    MEDICINA-LITHUANIA, 2024, 60 (07):
  • [46] Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines
    Kelso, John M.
    VACCINE, 2021, 39 (06) : 865 - 867
  • [47] Immunogenicity and Safety of an Inactivated Virus Vaccine Against SARS-CoV-2 in Patients with Autoimmune Rheumatic Diseases
    Medeiros-Ribeiro, Ana
    Aikawa, Nadia
    Schahin Saad, Carla Goncalves
    Vieira Neves Yuki, Emily Figueiredo
    Pedrosa, Tatiana do Nascimento
    Fusco, Solange
    Rojo, Priscila
    Pereira, Rosa
    Shinjo, Samuel
    Andrade, Danieli
    Sampaio-Barros, Percival
    Ribeiro, Carolina
    Deveza, Giordano
    de Oliveira Martins, Victor Adriano
    Silva, Clovis Artur
    Lopes, Marta
    Duarte, Alberto
    Antonangelo, Leila
    Sabino, Ester
    Kallas, Esper
    Pasoto, Sandra Gofinet
    Bonfa, Eloisa
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3260 - 3263
  • [48] EARLY SAFETY OF SARS-CoV-2 MRNA VACCINES IN SOLID ORGAN TRANSPLANT RECIPIENTS
    Ou, Michael
    Boyarsky, Brian
    Motter, Jennifer
    Greenberg, Ross
    Teles, Aura
    Ruddy, Jake
    Krach, Michelle
    Werbel, William
    Avery, Robin K.
    Massie, Allan
    Segev, Dorry
    Garonzik-Wang, Jacqueline
    TRANSPLANT INTERNATIONAL, 2021, 34 : 208 - 209
  • [49] Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer
    Chebel, Roy
    Labaki, Chris
    Farhat, Maria
    Kattan, Joseph
    FUTURE VIROLOGY, 2021, 16 (07) : 443 - 446
  • [50] Adverse cutaneous reactions after mRNA SARS-CoV-2 vaccination in 3 patients: a spectrum of severity
    Edgerley, Sarah
    Jeimy, Samira
    Zhu, Rongbo
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (23) : E807 - E811
12345